MRI guided Focal Cryotherapy of Prostate Cancer using Artemis fusion platform
July 2020

A group of urologists from Weill Cornell Medicine, New York, NY and Urological Research Network, Miami, FL has presented an interesting pilot study of the feasibility and reproducibility of performing MR/US cryoablation using the MR/US fusion from the Artemis® platform in a step-by-step video at AUA University podcast online.

Their conclusions:

  • transperineal MR/US fusion guided cryotherapy is safe and feasible under local anesthesia in an office setting. 
  • this in-office paradigm has the potential to decrease costs in the setting of value-based care.
  • The Artemis® fusion platform may be used to precisely ablate MRI lesions with biopsy proven, clinically significant prostate cancer.

For more information please see the video presentation:

Back to main Go to news
This site uses cookies to improve your user experience. You may find out more about in our Privacy Policy. By using this website you accept our use of cookies.